Anterior pituitary hormones Flashcards
1
Q
Prolactin, LH, FSH and their effects
A
- Prolactin: promotes milk secretion and maternal behavior
- Prolactin release is NEGATIVELY regulated by DA (only hormone that is regulated via inhibition rather than stimulation)
- Prolactin inhibits GnRH release and thus reduces levels of LH and FSH when prolactin is very high
- LH: in females it stimulates the ovulation, in males it stimulates testosterone secretion
- FSH: stimulates ovarian follicle growth, in males it stimulates spermatogenesis
- Both LH and FSH are controlled by GnRH release from hypothalamus
2
Q
Control of prolactin release
A
- Primarily controlled by DA: increased DA release from the hypothalamus leads to suppressed prolactin release
- Suckling of the breast stimulates prolactin release
- High levels of estrogen inhibit prolactin release whereas moderate estrogen levels stimulate prolactin release
- Prolactin inhibits GnRH release from hypothalamus and thus reduces LH, FHS, and downstream hormone levels (estrogen, testosterone)
- This helps to delay the next pregnancy by decreasing libido while breastfeeding
3
Q
Control of FSH and LH
A
- Both lead to the release of estrogen, LH leads to the release of testosterone (in the ovaries or testes)
- Testosterone and estrogen feedback on the pituitary to inhibit FSH/LH release
- Estrogen also will decrease prolactin release at high levels, and stimulate prolactin release at moderate levels
4
Q
Hyper and hypoprolactinemia
A
- Hypoprolactinemia can result from pituitary damage and produce a failure to lactate (no Rx)
- Hyperprolactinemia is usually from prolactinoma (most common pituitary tumor)
- Rx is DA agonist drugs: bromocriptine and cabergoline
5
Q
Posterior pituitary hormones
A
- ADH: promotes renal water (and Na) retention
- Central DI: failure of pituitary to release ADH
- Nephrogenic DI: failure of kidneys to respond to ADH
- Oxytocin: acts on breast to eject milk and causes uteral contractions
6
Q
Growth Hormone
A
- AKA somatotropin, GH is not conserved btwn species thus we must give human GH (hGH) as Rx
- Synthesized in anterior pituitary and accounts for 10% of its weight
- GH circulates bound to a carrier
- Pulsatile GH Rx is more effective than continuous GH (is released in a pulsatile manner in vivo)
7
Q
Effects of GH
A
- GH spares glucose utilization, increases availability of FAs, promotes AA uptake and protein synthesis
- Free FA increase will decrease vlc utilization and make tissues resistant to insulin
- GH is diabetogenic (spares glc, favors burning of fat) despite causing the release of IGF1, which can increase glc uptake and utilization
- GH promotes growth in size of limbs and internal organs
- GH is one of the primary hormones that regulates protein synthesis (increases it)
8
Q
IGF1
A
- IGF1 is released in the liver in response to GH and has a number of effects
- One of primary purposes of IGF1 is to regulate glc uptake and utilization in the fasted state (when insulin is suppressed)
- Insulin also causes the release of IGF1, so it does play a role in the well-fed state
- IGF1 and IGF2 (less important) are similar in structure to insulin, but the C peptide remains on IGFs
- IGF1 is the primary IGF that regulates growth
9
Q
Roles of GH and IGF
A
- Increase of GH causes the liver to increase GNG (diabetogenic), protein synthesis, and IGF release
- In adipose tissue, GH causes decreased glc uptake and increased lipolysis (both are diabetogenic)
- In muscle GH causes decreased glc uptake (diabetogenic), increased AA uptake, and increased protein synthesis
- In bone IGF1 causes increased linear growth and increased cell size/number
- In other organs IGF causes increase cell size/number
10
Q
Regulation of GH release 1
A
- GH primarily controlled by the hypothalamus via GHRH (positive regulation) and somatostatin (negative regulation)
- Increase in GHRH and/or a decrease in somatostatin causes GH release, leading to a rise in IGF
- IGF feeds back to pituitary (shuts off GH release) and hypothalamus (increases somatostatin thus decreases GH release)
- GH feeds back to hypothalamus to increase somatostatin release and reduce GH release
11
Q
Regulation of GH release 2
A
- GHRH negatively feeds back on itself
- Fasting and high protein meals increases GHRH release
- High glc increases somatostatin release and decreases GH
- Hypoglycemia causes GH release (insulin induced or fasting)
- Insulin-induced hypoglycemia can be used to test for normal GH response
- Decreased FFA levels will increase GH release
- Sleep increases GH release
- Somatostatin will usually override GHRH
12
Q
GHRH and somatostatin
A
- GHRH source is hypothalamus, has been used to Rx slow growing children
- Very little GHRH is found in plasma
- Somatostatin is synthesized in the brain but also other tissues
- Particularly synthesized in pancreas where it suppresses insulin release
13
Q
Hyper secretion of GH
A
- Can result from pituitary tumors w/ activating mutations
- If hyper secretion occurs before bone epiphyses close (early life) leads to giantism
- Characterized by increased linear bone growth: long arms and legs
- If hyper secretion occurs after epiphyses close leads to acromegaly
- Characterized by bone growth (and thus large) fingers, toes, hands, feet, jaw, head
- To Rx this condition (besides surgery), can use drugs that target the GH receptor
- The receptor requires dimerization (w/ 1 molecule of GH) for any action, thus a GH analog (pegvisomant) that inhibits dimerization b/c it lacks 1 binding site will reduce GH activity
14
Q
Hyposecretion of GH
A
- Lack of GH release results in dwarfism if the deficit occurs in childhood
- Giving hGH can restore growth
- In adults lack of GH has no obvious signs
- GH resistance (laron syndrome) can cause the same problems in children and is due to inactivating mutations in GH receptor
- Cannot Rx them w/ hGH, must Rx w/ IGF1